APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tafenoquine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Tafenoquine Market Outlook and Growth Opportunities 2026

2 January 2026190 pages

Choose your research edition.

Industry ResearchTafenoquine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Tafenoquine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Tafenoquine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tafenoquine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Tafenoquine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Tafenoquine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tafenoquine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Tafenoquine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Tafenoquine market include Pharmacodia (Beijing) Co.,Ltd, Merck, GlaxoSmithKline Pharmaceuticals (GSK), WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., J & K Scientific LTD, BOC Sciences and Amadis Chemical Company Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tafenoquine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tafenoquine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tafenoquine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tafenoquine market size, projected growth trends, production technologies, key applications, and end-use industries.

Tafenoquine Segment by Company

Pharmacodia (Beijing) Co.,Ltd

Merck

GlaxoSmithKline Pharmaceuticals (GSK)

WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.

J & K Scientific LTD

BOC Sciences

Amadis Chemical Company Limited

Tafenoquine Segment by Type

Powder

Pills

Tafenoquine Segment by Application

P. falciparum Treatment

Radical Cure of P.vivax

Prevention of Malaria Relapse

Tafenoquine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Tafenoquine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Tafenoquine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Tafenoquine significant trends, drivers, influence factors in global and regions.

6. To analyze Tafenoquine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tafenoquine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tafenoquine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tafenoquine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tafenoquine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Tafenoquine industry.

Chapter 3: Detailed analysis of Tafenoquine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Tafenoquine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Tafenoquine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Tafenoquine Industry Trends Table 2. Tafenoquine Industry Drivers Table 3. Tafenoquine Industry Opportunities and Challenges Table 4. Tafenoquine Industry Restraints Table 5. Global Tafenoquine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Tafenoquine Revenue Share by Company (2021-2026) Table 7. Global Tafenoquine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Tafenoquine Sales Volume Share by Company (2021-2026) Table 9. Global Tafenoquine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Tafenoquine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Tafenoquine Key Company Manufacturing Base & Headquarters Table 12. Global Tafenoquine Company, Product Type & Application Table 13. Global Tafenoquine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Tafenoquine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Powder Table 18. Significant Companies of Pills Table 19. Global Tafenoquine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Tafenoquine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Tafenoquine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Tafenoquine Sales Volume Share by Type (2021-2026) Table 23. Global Tafenoquine Sales Volume Share by Type (2027-2032) Table 24. Global Tafenoquine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Tafenoquine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Tafenoquine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Tafenoquine Sales Value Share by Type (2021-2026) Table 28. Global Tafenoquine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of P. falciparum Treatment Table 30. Significant Companies of Radical Cure of P.vivax Table 31. Significant Companies of Prevention of Malaria Relapse Table 32. Global Tafenoquine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Tafenoquine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Tafenoquine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Tafenoquine Sales Volume Share by Application (2021-2026) Table 36. Global Tafenoquine Sales Volume Share by Application (2027-2032) Table 37. Global Tafenoquine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Tafenoquine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Tafenoquine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Tafenoquine Sales Value Share by Application (2021-2026) Table 41. Global Tafenoquine Sales Value Share by Application (2027-2032) Table 42. Global Tafenoquine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Tafenoquine Sales by Region (2021-2026) & (K Units) Table 44. Global Tafenoquine Sales Market Share by Region (2021-2026) Table 45. Global Tafenoquine Sales by Region (2027-2032) & (K Units) Table 46. Global Tafenoquine Sales Market Share by Region (2027-2032) Table 47. Global Tafenoquine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Tafenoquine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Tafenoquine Sales Value Share by Region (2021-2026) Table 50. Global Tafenoquine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Tafenoquine Sales Value Share by Region (2027-2032) Table 52. Global Tafenoquine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Tafenoquine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Tafenoquine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Tafenoquine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Tafenoquine Sales by Country (2021-2026) & (K Units) Table 57. Global Tafenoquine Sales Market Share by Country (2021-2026) Table 58. Global Tafenoquine Sales by Country (2027-2032) & (K Units) Table 59. Global Tafenoquine Sales Market Share by Country (2027-2032) Table 60. Global Tafenoquine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Tafenoquine Sales Value Market Share by Country (2021-2026) Table 62. Global Tafenoquine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Tafenoquine Sales Value Market Share by Country (2027-2032) Table 64. Pharmacodia (Beijing) Co.,Ltd Company Information Table 65. Pharmacodia (Beijing) Co.,Ltd Business Overview Table 66. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio Table 68. Pharmacodia (Beijing) Co.,Ltd Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Tafenoquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Merck Tafenoquine Product Portfolio Table 73. Merck Recent Development Table 74. GlaxoSmithKline Pharmaceuticals (GSK) Company Information Table 75. GlaxoSmithKline Pharmaceuticals (GSK) Business Overview Table 76. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio Table 78. GlaxoSmithKline Pharmaceuticals (GSK) Recent Development Table 79. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information Table 80. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview Table 81. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio Table 83. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Development Table 84. J & K Scientific LTD Company Information Table 85. J & K Scientific LTD Business Overview Table 86. J & K Scientific LTD Tafenoquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. J & K Scientific LTD Tafenoquine Product Portfolio Table 88. J & K Scientific LTD Recent Development Table 89. BOC Sciences Company Information Table 90. BOC Sciences Business Overview Table 91. BOC Sciences Tafenoquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. BOC Sciences Tafenoquine Product Portfolio Table 93. BOC Sciences Recent Development Table 94. Amadis Chemical Company Limited Company Information Table 95. Amadis Chemical Company Limited Business Overview Table 96. Amadis Chemical Company Limited Tafenoquine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Amadis Chemical Company Limited Tafenoquine Product Portfolio Table 98. Amadis Chemical Company Limited Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Tafenoquine Distributors List Table 102. Tafenoquine Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Tafenoquine Product Image Figure 2. Global Tafenoquine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tafenoquine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Tafenoquine Sales (2021-2032) & (K Units) Figure 5. Global Tafenoquine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Tafenoquine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Powder Image Figure 10. Pills Image Figure 11. Global Tafenoquine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Tafenoquine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Tafenoquine Sales Volume Share by Type (2021-2032) Figure 14. Global Tafenoquine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Tafenoquine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Tafenoquine Sales Value Share by Type (2021-2032) Figure 17. P. falciparum Treatment Image Figure 18. Radical Cure of P.vivax Image Figure 19. Prevention of Malaria Relapse Image Figure 20. Global Tafenoquine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Tafenoquine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Tafenoquine Sales Volume Share by Application (2021-2032) Figure 23. Global Tafenoquine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Tafenoquine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Tafenoquine Sales Value Share by Application (2021-2032) Figure 26. Global Tafenoquine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Tafenoquine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Tafenoquine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Tafenoquine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Tafenoquine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Tafenoquine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Tafenoquine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Tafenoquine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Tafenoquine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Tafenoquine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Tafenoquine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Tafenoquine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Tafenoquine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Tafenoquine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Tafenoquine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Tafenoquine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Tafenoquine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Tafenoquine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Tafenoquine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Pills
Applications
  • P. falciparum Treatment
  • Radical Cure of P.vivax
  • Prevention of Malaria Relapse
Companies covered
  • Pharmacodia (Beijing) Co.,Ltd
  • Merck
  • GlaxoSmithKline Pharmaceuticals (GSK)
  • WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
  • J & K Scientific LTD
  • BOC Sciences
  • Amadis Chemical Company Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tafenoquine Sales Value (2021-2032)
  4. 1.2.2 Global Tafenoquine Sales Volume (2021-2032)
  5. 1.2.3 Global Tafenoquine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Tafenoquine Market Dynamics
  1. 2.1 Tafenoquine Industry Trends
  2. 2.2 Tafenoquine Industry Drivers
  3. 2.3 Tafenoquine Industry Opportunities and Challenges
  4. 2.4 Tafenoquine Industry Restraints
3 Tafenoquine Market by Company
  1. 3.1 Global Tafenoquine Company Revenue Ranking in 2025
  2. 3.2 Global Tafenoquine Revenue by Company (2021-2026)
  3. 3.3 Global Tafenoquine Sales Volume by Company (2021-2026)
  4. 3.4 Global Tafenoquine Average Price by Company (2021-2026)
  5. 3.5 Global Tafenoquine Company Ranking (2024-2026)
  6. 3.6 Global Tafenoquine Company Manufacturing Base and Headquarters
  7. 3.7 Global Tafenoquine Company Product Type and Application
  8. 3.8 Global Tafenoquine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Tafenoquine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Tafenoquine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Tafenoquine Market by Type
  1. 4.1 Tafenoquine Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Pills
  4. 4.2 Global Tafenoquine Sales Volume by Type
  5. 4.2.1 Global Tafenoquine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tafenoquine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Tafenoquine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Tafenoquine Sales Value by Type
  9. 4.3.1 Global Tafenoquine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tafenoquine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Tafenoquine Sales Value Share by Type (2021-2032)
5 Tafenoquine Market by Application
  1. 5.1 Tafenoquine Application Introduction
  2. 5.1.1 P. falciparum Treatment
  3. 5.1.2 Radical Cure of P.vivax
  4. 5.1.3 Prevention of Malaria Relapse
  5. 5.2 Global Tafenoquine Sales Volume by Application
  6. 5.2.1 Global Tafenoquine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tafenoquine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Tafenoquine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Tafenoquine Sales Value by Application
  10. 5.3.1 Global Tafenoquine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tafenoquine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Tafenoquine Sales Value Share by Application (2021-2032)
6 Tafenoquine Regional Sales and Value Analysis
  1. 6.1 Global Tafenoquine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tafenoquine Sales by Region (2021-2032)
  3. 6.2.1 Global Tafenoquine Sales by Region: 2021-2026
  4. 6.2.2 Global Tafenoquine Sales by Region (2027-2032)
  5. 6.3 Global Tafenoquine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Tafenoquine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Tafenoquine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Tafenoquine Sales Value by Region (2027-2032)
  9. 6.5 Global Tafenoquine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Tafenoquine Sales Value (2021-2032)
  12. 6.6.2 North America Tafenoquine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Tafenoquine Sales Value (2021-2032)
  15. 6.7.2 Europe Tafenoquine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Tafenoquine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Tafenoquine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Tafenoquine Sales Value (2021-2032)
  21. 6.9.2 South America Tafenoquine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Tafenoquine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Tafenoquine Sales Value Share by Country, 2025 VS 2032
7 Tafenoquine Country-level Sales and Value Analysis
  1. 7.1 Global Tafenoquine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Tafenoquine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Tafenoquine Sales by Country (2021-2032)
  4. 7.3.1 Global Tafenoquine Sales by Country (2021-2026)
  5. 7.3.2 Global Tafenoquine Sales by Country (2027-2032)
  6. 7.4 Global Tafenoquine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Tafenoquine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Tafenoquine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Tafenoquine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Tafenoquine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Tafenoquine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Tafenoquine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Tafenoquine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Tafenoquine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Tafenoquine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Tafenoquine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Tafenoquine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Tafenoquine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Tafenoquine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Tafenoquine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Tafenoquine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Tafenoquine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Tafenoquine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Tafenoquine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Tafenoquine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Tafenoquine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Tafenoquine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Tafenoquine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Tafenoquine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Tafenoquine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Tafenoquine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Tafenoquine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Tafenoquine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Tafenoquine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Tafenoquine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Tafenoquine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Tafenoquine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Tafenoquine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Tafenoquine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Tafenoquine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Tafenoquine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Tafenoquine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Tafenoquine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Tafenoquine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Tafenoquine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Tafenoquine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Tafenoquine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Tafenoquine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Tafenoquine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Tafenoquine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Tafenoquine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Tafenoquine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Tafenoquine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Tafenoquine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Tafenoquine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Tafenoquine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Tafenoquine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Tafenoquine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Tafenoquine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Tafenoquine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Tafenoquine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Tafenoquine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Tafenoquine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Tafenoquine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Tafenoquine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Tafenoquine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Tafenoquine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Tafenoquine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Tafenoquine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Tafenoquine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Tafenoquine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Tafenoquine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Tafenoquine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Tafenoquine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Tafenoquine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Tafenoquine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Tafenoquine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Tafenoquine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Tafenoquine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Tafenoquine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Tafenoquine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Tafenoquine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Tafenoquine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Tafenoquine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Tafenoquine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Tafenoquine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Tafenoquine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Tafenoquine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Tafenoquine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Tafenoquine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Tafenoquine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Tafenoquine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pharmacodia (Beijing) Co.,Ltd
  2. 8.1.1 Pharmacodia (Beijing) Co.,Ltd Company Information
  3. 8.1.2 Pharmacodia (Beijing) Co.,Ltd Business Overview
  4. 8.1.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
  6. 8.1.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Tafenoquine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Tafenoquine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 GlaxoSmithKline Pharmaceuticals (GSK)
  14. 8.3.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Information
  15. 8.3.2 GlaxoSmithKline Pharmaceuticals (GSK) Business Overview
  16. 8.3.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
  18. 8.3.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments
  19. 8.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
  20. 8.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
  21. 8.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Business Overview
  22. 8.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
  24. 8.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments
  25. 8.5 J & K Scientific LTD
  26. 8.5.1 J & K Scientific LTD Company Information
  27. 8.5.2 J & K Scientific LTD Business Overview
  28. 8.5.3 J & K Scientific LTD Tafenoquine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 J & K Scientific LTD Tafenoquine Product Portfolio
  30. 8.5.5 J & K Scientific LTD Recent Developments
  31. 8.6 BOC Sciences
  32. 8.6.1 BOC Sciences Company Information
  33. 8.6.2 BOC Sciences Business Overview
  34. 8.6.3 BOC Sciences Tafenoquine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BOC Sciences Tafenoquine Product Portfolio
  36. 8.6.5 BOC Sciences Recent Developments
  37. 8.7 Amadis Chemical Company Limited
  38. 8.7.1 Amadis Chemical Company Limited Company Information
  39. 8.7.2 Amadis Chemical Company Limited Business Overview
  40. 8.7.3 Amadis Chemical Company Limited Tafenoquine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
  42. 8.7.5 Amadis Chemical Company Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tafenoquine Value Chain Analysis
  2. 9.1.1 Tafenoquine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tafenoquine Sales Mode & Process
  6. 9.2 Tafenoquine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tafenoquine Distributors
  9. 9.2.3 Tafenoquine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst